Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

NYSE:DNA   4:00:00 PM EDT
+0.05 (+3.60%)
7:56:27 PM EDT: $1.44 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.82B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$42.54 Million
Adjusted EPS-$0.10
See more estimates
10-Day MA$1.44
50-Day MA$1.56
200-Day MA$1.64
See more pivots

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A Stock, NYSE:DNA

27 Drydock Avenue, 8th floor, Boston, Massachusetts 02210
United States of America
Phone: +1.877.422.5362
Number of Employees: 1292


Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.